Mankind Pharma Limited
MANKIND
Hisse Senetlerindeki Sıralama
#2064
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
Hisse Fiyatı
$24.08
Piyasa Değeri
$9.95B
Değişim (1 gün)
-4.09%
Değişim (1 yıl)
-13.33%
Ülke
IN
Ticaret Mankind Pharma Limited (MANKIND)
Kategori
Healthcare
Mankind Pharma Limited (MANKIND) için tedavüldeki hisse sayısı
October 2026 itibarıyla tedavüldeki hisse sayısı: 0
Mankind Pharma Limited şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 0'dir. October 2026 sonunda şirketin 0 tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
Mankind Pharma Limited (MANKIND) için 2019 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
| Yıl | Tedavüldeki Hisse Sayısı | Değiştir |
|---|---|---|
| 2025 | 404.67M | 1.02% |
| 2024 | 400.59M | 0.00% |
| 2023 | 400.59M | 0.00% |
| 2022 | 400.59M | 0.00% |
| 2021 | 400.59M | 0.00% |
| 2020 | 400.59M | 0.00% |
| 2019 | 400.59M | 0.00% |
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
| Şirket | Tedavüldeki Hisse Sayısı | Fark | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
